NO981000L - 4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelse - Google Patents
4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelseInfo
- Publication number
- NO981000L NO981000L NO981000A NO981000A NO981000L NO 981000 L NO981000 L NO 981000L NO 981000 A NO981000 A NO 981000A NO 981000 A NO981000 A NO 981000A NO 981000 L NO981000 L NO 981000L
- Authority
- NO
- Norway
- Prior art keywords
- piperidine
- group
- cycloalkyl
- therapeutic use
- cycloalkylalkyl
- Prior art date
Links
- 125000000753 cycloalkyl group Chemical group 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000004090 neuroprotective agent Substances 0.000 abstract 1
- 230000000508 neurotrophic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9510513A FR2738566B1 (fr) | 1995-09-08 | 1995-09-08 | Derives de 4-(cycloalkyl)piperidines et de 4-(cycloalkylalkyl)piperidines, leur preparation et leur application en therapeutique |
| FR9510512A FR2738568B1 (fr) | 1995-09-08 | 1995-09-08 | Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique |
| PCT/FR1996/001362 WO1997009309A1 (fr) | 1995-09-08 | 1996-09-05 | Derives de 4-(cycloalkyl)piperidines et de 4-(cycloalkylalkyl)pi peridines, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981000D0 NO981000D0 (no) | 1998-03-06 |
| NO981000L true NO981000L (no) | 1998-05-08 |
Family
ID=26232195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981000A NO981000L (no) | 1995-09-08 | 1998-03-06 | 4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelse |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0848707B1 (cs) |
| JP (1) | JPH11514975A (cs) |
| KR (1) | KR19990044479A (cs) |
| CN (1) | CN1201453A (cs) |
| AR (1) | AR003530A1 (cs) |
| AT (1) | ATE182885T1 (cs) |
| AU (1) | AU703776B2 (cs) |
| BG (1) | BG102282A (cs) |
| BR (1) | BR9610408A (cs) |
| CA (1) | CA2231326A1 (cs) |
| CO (1) | CO4750660A1 (cs) |
| CZ (1) | CZ66598A3 (cs) |
| DE (1) | DE69603613T2 (cs) |
| EE (1) | EE9800064A (cs) |
| ES (1) | ES2137015T3 (cs) |
| GR (1) | GR3031513T3 (cs) |
| HU (1) | HUP9802938A2 (cs) |
| IL (1) | IL123557A0 (cs) |
| NO (1) | NO981000L (cs) |
| NZ (1) | NZ316981A (cs) |
| PL (1) | PL325421A1 (cs) |
| SI (1) | SI0848707T1 (cs) |
| SK (1) | SK31198A3 (cs) |
| TR (1) | TR199800407T1 (cs) |
| WO (1) | WO1997009309A1 (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU727080B2 (en) | 1997-06-30 | 2000-11-30 | Allergan, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
| JP2002528416A (ja) | 1998-10-27 | 2002-09-03 | アルコン ラボラトリーズ， インコーポレーテッド | 外網膜の疾患の治療 |
| CN1964627B (zh) * | 2004-06-04 | 2011-10-19 | 华盛顿大学 | 治疗神经病变的方法和组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4028366A (en) * | 1975-01-20 | 1977-06-07 | Sterling Drug Inc. | 2-Naphthyl-lower-alkanoylamines |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
| FR2684379B1 (fr) * | 1991-12-02 | 1995-04-28 | Synthelabo | Derives de piperidine, leur preparation et leur application en therapeutique. |
| WO1994018172A1 (fr) * | 1993-02-01 | 1994-08-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose d'imidazolylbenzene et son utilisation comme medicament |
-
1996
- 1996-09-05 SI SI9630106T patent/SI0848707T1/xx unknown
- 1996-09-05 TR TR1998/00407T patent/TR199800407T1/xx unknown
- 1996-09-05 DE DE69603613T patent/DE69603613T2/de not_active Expired - Fee Related
- 1996-09-05 CA CA002231326A patent/CA2231326A1/en not_active Abandoned
- 1996-09-05 PL PL96325421A patent/PL325421A1/xx unknown
- 1996-09-05 EE EE9800064A patent/EE9800064A/xx unknown
- 1996-09-05 KR KR1019980701727A patent/KR19990044479A/ko not_active Withdrawn
- 1996-09-05 ES ES96930216T patent/ES2137015T3/es not_active Expired - Lifetime
- 1996-09-05 NZ NZ316981A patent/NZ316981A/xx unknown
- 1996-09-05 AU AU69344/96A patent/AU703776B2/en not_active Ceased
- 1996-09-05 CZ CZ98665A patent/CZ66598A3/cs unknown
- 1996-09-05 HU HU9802938A patent/HUP9802938A2/hu unknown
- 1996-09-05 JP JP9510910A patent/JPH11514975A/ja active Pending
- 1996-09-05 IL IL12355796A patent/IL123557A0/xx unknown
- 1996-09-05 CO CO96047348A patent/CO4750660A1/es unknown
- 1996-09-05 BR BR9610408A patent/BR9610408A/pt not_active Application Discontinuation
- 1996-09-05 AT AT96930216T patent/ATE182885T1/de active
- 1996-09-05 CN CN96198170A patent/CN1201453A/zh active Pending
- 1996-09-05 EP EP96930216A patent/EP0848707B1/fr not_active Expired - Lifetime
- 1996-09-05 WO PCT/FR1996/001362 patent/WO1997009309A1/fr not_active Ceased
- 1996-09-05 SK SK311-98A patent/SK31198A3/sk unknown
- 1996-09-06 AR ARP960104270A patent/AR003530A1/es unknown
-
1998
- 1998-02-26 BG BG102282A patent/BG102282A/xx unknown
- 1998-03-06 NO NO981000A patent/NO981000L/no unknown
-
1999
- 1999-10-13 GR GR990402608T patent/GR3031513T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0848707A1 (fr) | 1998-06-24 |
| KR19990044479A (ko) | 1999-06-25 |
| CO4750660A1 (es) | 1999-03-31 |
| EE9800064A (et) | 1998-08-17 |
| HUP9802938A2 (hu) | 1999-10-28 |
| MX9801838A (es) | 1998-08-30 |
| SI0848707T1 (en) | 2000-02-29 |
| AU6934496A (en) | 1997-03-27 |
| DE69603613T2 (de) | 2000-03-02 |
| NZ316981A (en) | 1998-12-23 |
| SK31198A3 (en) | 1998-08-05 |
| JPH11514975A (ja) | 1999-12-21 |
| ES2137015T3 (es) | 1999-12-01 |
| DE69603613D1 (de) | 1999-09-09 |
| BG102282A (en) | 1998-09-30 |
| PL325421A1 (en) | 1998-07-20 |
| EP0848707B1 (fr) | 1999-08-04 |
| CN1201453A (zh) | 1998-12-09 |
| WO1997009309A1 (fr) | 1997-03-13 |
| ATE182885T1 (de) | 1999-08-15 |
| GR3031513T3 (en) | 2000-01-31 |
| BR9610408A (pt) | 1999-07-06 |
| AR003530A1 (es) | 1998-08-05 |
| IL123557A0 (en) | 1998-10-30 |
| CZ66598A3 (cs) | 1998-06-17 |
| NO981000D0 (no) | 1998-03-06 |
| AU703776B2 (en) | 1999-04-01 |
| CA2231326A1 (en) | 1997-03-13 |
| TR199800407T1 (xx) | 1998-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0017025A (pt) | Antagonistas do receptor y5 do neuropeptìdeo y de imidazola substituìda | |
| NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
| MEP12708A (en) | Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
| ATE250590T1 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
| ATE96437T1 (de) | (1-hydroxy-2-piperidinylalkyl)-2-indolon, 2quinolinon, 2-benzo(b>azepinon, 2-benzimidazolon und 2-quinazolinon-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
| DK117087A (da) | Heterocycliske forbindelser, deres fremstilling oganvendelse som insekticider | |
| PT1158973E (pt) | Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| MY117803A (en) | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
| NO921944L (no) | Benzofuran-derivater | |
| MXPA03011722A (es) | Derivados de piperidina utiles como moduladores de actividad de quimiocina. | |
| ATE147071T1 (de) | 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung | |
| NO961000L (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| ATE128463T1 (de) | Piperidin und pyrrolidin derivate. | |
| NO972887L (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
| DK0508740T3 (da) | Thiazolidindionderivater, deres fremstilling og anvendelse. | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO995590L (no) | 20-Aryl-5<alfa>-pregnan-derivater | |
| NO983472L (no) | Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| NO981000L (no) | 4-(cykloalkyl)piperidin og 4-(cykloalkylalkyl)piperidin derivater, deres fremstilling og terapeutiske anvendelse | |
| NO20023251D0 (no) | Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme | |
| NO991581L (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler |